Retina Research Shifting Toward More Durable, Sustained Treatments
Presenters at the AAO 2025 meeting outlined a future for retinal care that reduces patient burden by reconsidering treatment delivery methods.
During the last couple of decades, retina specialists have seen their fair share of innovation, from long-acting anti-vascular endothelial growth factor (VEGF) agents, such as faricimab and high-dose aflibercept, to laser treatments and next-generation diagnostic imaging.
For macular edema, management has changed dramatically over the past decade, including application of new imaging technologies, understanding of pathophysiology, and individualization of treatments, pharmacotherapies, and surgical approaches, said
Mark W. Johnson, MD, of University of Michigan Kellogg Eye Centerat the 2025 American Academy of Ophthalmology (AAO) meeting.
Despite the many advances in retinal disease, real-world data show persistent gaps in effective treatment.
Author's summary: Research shifts toward durable retinal treatments.
More News
- Dean Lewis Shares Statement Following Misconduct Allegations
- 2025 NBA Cup TRACKER: Scores, Schedule, Standings
- Stranger Things 5 trailer shows way more than we were ready for
- Cobb public libraries to hold children's Halloween events
- After Busy October, Plenty of News Still Could Be Made in November
- Ex-Tesla Engineers Just Built A Speedster Before Elon Finished His Roadster | Carscoops
- Billie Eilish Calls on Billionaires to Do More for People in Need
- Park | Sliwa Should Not and Will Not Drop Out
- Banks’ Worry Over Stablecoins ‘Ignores Reality,’ Says Coinbase | HODL FM
- Mason County receives thousands of books for miniature libraries | Ledger Independent - Maysville Online